Literature DB >> 33852188

Monoallelic Mutations in SLCO2A1 Cause Autosomal Dominant Primary Hypertrophic Osteoarthropathy.

Yang Xu1, Zeng Zhang1, Hua Yue1, Shanshan Li1, Zhenlin Zhang1.   

Abstract

Primary hypertrophic osteoarthropathy (PHO) is a rare disease inherited as a recessive or irregular dominant trait and characterized by digital clubbing, pachydermia and periostosis. Biallelic mutations in HPGD and SLCO2A1, disturbing prostaglandin E2 (PGE2 ) catabolism and leading to increased circulating PGE2 level, cause PHO autosomal recessive 1 (PHOAR1) and PHO autosomal recessive 2 (PHOAR2), respectively. However, no causative genes have been reported for PHO autosomal dominant (PHOAD). Here, we performed Sanger sequencing and the whole-genome sequencing (WGS) on DNA samples from seven Chinese PHOAD families, and after excluding other single nucleotide variants (SNVs), structural variations (SVs) and copy number variations (CNVs) in the genomes, we reported six SLCO2A1 monoallelic mutations (c.1660G>A [p.G554R], c.664G>A [p.G222R], c.1106G>A [p.G369D], c.1065dupA [p.Q356TfsX77], c.1293delT [p.S432AfsX48] and c.1807C>T [p.R603X]) in the probands and affected family members. Then, in five other PHO families with probands carrying SLCO2A1 biallelic mutations, we verified that parents with SLCO2A1 monoallelic mutations also displayed PHO manifestations, which further confirmed the pathogenicity of SLCO2A1 monoallelic mutations and illustrated the allelic nature of PHOAD and PHOAR2. Subsequently, through comparison of 7 PHOAD probands and 50 PHOAR2 patients, we found onset age in puberty and skewed penetrance rate were similar in both PHO types, but symptoms and signs of PHOAD were milder, including less severe pachydermia (p=0.027) and periostosis (p=0.005), and less frequent cutis verticis gyrata (p=0.011), acne (p=0.005), arthralgia (p=0.037) and anemia (p=0.023). The median urinary PGE2 level in PHOAD probands was almost half that in PHOAR2 patients (PHOAD 277.58 ng/mmoL creatinine, PHOAR2 473.19 ng/mmoL creatinine; p=0.038). Moreover, through the 3-month trial of oral administration of Etoricoxib, an effective response similar to that we reported previously in PHOAR2 patients was observed in PHOAD probands. In conclusion, our findings confirm that SLCO2A1 monoallelic mutations are the cause of PHOAD and broaden phenotypic spectrum of PHO. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

Entities:  

Keywords:  Autosomal dominant primary hypertrophic osteoarthropathy; Etoricoxib; PGE2; SLCO2A1; monoallelic mutations

Year:  2021        PMID: 33852188     DOI: 10.1002/jbmr.4310

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  2 in total

1.  Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Cutis Verticis Gyrata: Case Report and Review of Literature.

Authors:  Yifan Wang; Shan Wang; Liyun Zheng; Xiuli Wang; Hui Wang; Zhenyu Zhong; Siqi Liu; Xiaodong Zheng; Min Gao
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-23

2.  Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations.

Authors:  Qi Lu; Yang Xu; Shanshan Li; Zeng Zhang; Jiagen Sheng; Zhenlin Zhang
Journal:  Int J Biol Sci       Date:  2022-06-06       Impact factor: 10.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.